The Montreal Clinical Research Institute (IRCM) warmly congratulates its researcher Mathieu Ferron Director of the IRCM's Molecular Physiology Research Unit, Associate Professor at Université de Montréal (UdeM) and Assistant Professor at McGill University, who officially received the Prix reconnaissance Recherche-début de carrière from the Université de Montréal's Department of Medicine on May 30.
Dr. Ferron and his team regularly distinguish themselves in the research world by their work, which advances knowledge and gives hope of reversing a number of debilitating pathologies. Most recently, in a salutary advance in our understanding of the mechanisms underlying diabetes, a pathology affecting 1 in 11 people worldwide, his team identified a new role for vitamin K and gamma-carboxylation in beta cells, and their potentially protective role against diabetes - a first in fifteen years of basic research.
‘’It's heartwarming to see the hard work that is essential to cure-oriented discoveries rewarded in this way, and I would like to offer my congratulations to Mathieu Ferron," said Dr. Jean-François Côté, President and Scientific Director of the IRCM.
In 2021, Dr. Ferron had already received the prestigious Fuller Albright Award from the American Society for Bone and Mineral Research (ASBMR) for excellence in research. The Fuller Albright Award is presented to an ASBMR member under the age of 45, in recognition of meritorious scientific achievement in skeletal and bone research.
